234 related articles for article (PubMed ID: 26376488)
1. Molecular Cloning and Functional Expression of the Equine K+ Channel KV11.1 (Ether à Go-Go-Related/KCNH2 Gene) and the Regulatory Subunit KCNE2 from Equine Myocardium.
Pedersen PJ; Thomsen KB; Olander ER; Hauser F; Tejada Mde L; Poulsen KL; Grubb S; Buhl R; Calloe K; Klaerke DA
PLoS One; 2015; 10(9):e0138320. PubMed ID: 26376488
[TBL] [Abstract][Full Text] [Related]
2. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.
Anderson CL; Delisle BP; Anson BD; Kilby JA; Will ML; Tester DJ; Gong Q; Zhou Z; Ackerman MJ; January CT
Circulation; 2006 Jan; 113(3):365-73. PubMed ID: 16432067
[TBL] [Abstract][Full Text] [Related]
3. Functional effects of a missense mutation in HERG associated with type 2 long QT syndrome.
Amorós I; Jiménez-Jáimez J; Tercedor L; Barana A; Gómez R; de la Fuente MG; Dolz-Gaitón P; Alvarez M; Martínez-Espín E; Lorente JA; Melgares R; Tamargo J; Delpón E; Caballero R
Heart Rhythm; 2011 Mar; 8(3):463-70. PubMed ID: 21109023
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and functional expression of the K
Pedersen PJ; Thomsen KB; Flak JB; Tejada MA; Hauser F; Trachsel D; Buhl R; Kalbfleisch T; DePriest MS; MacLeod JN; Calloe K; Klaerke DA
Res Vet Sci; 2017 Aug; 113():79-86. PubMed ID: 28917093
[TBL] [Abstract][Full Text] [Related]
5. Modulation of I(Kr) inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome.
Cordeiro JM; Brugada R; Wu YS; Hong K; Dumaine R
Cardiovasc Res; 2005 Aug; 67(3):498-509. PubMed ID: 16039272
[TBL] [Abstract][Full Text] [Related]
6. The voltage-gated channel accessory protein KCNE2: multiple ion channel partners, multiple ways to long QT syndrome.
Eldstrom J; Fedida D
Expert Rev Mol Med; 2011 Dec; 13():e38. PubMed ID: 22166675
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterisation of a novel KCNQ1 mutation in a family with Romano-Ward syndrome.
Zehelein J; Thomas D; Khalil M; Wimmer AB; Koenen M; Licka M; Wu K; Kiehn J; Brockmeier K; Kreye VA; Karle CA; Katus HA; Ulmer HE; Schoels W
Biochim Biophys Acta; 2004 Nov; 1690(3):185-92. PubMed ID: 15511625
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic basis for type 2 long QT syndrome caused by KCNH2 mutations that disrupt conserved arginine residues in the voltage sensor.
McBride CM; Smith AM; Smith JL; Reloj AR; Velasco EJ; Powell J; Elayi CS; Bartos DC; Burgess DE; Delisle BP
J Membr Biol; 2013 May; 246(5):355-64. PubMed ID: 23546015
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator.
Perry M; Sachse FB; Sanguinetti MC
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13827-32. PubMed ID: 17693551
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of KCNE1 induces QT interval prolongation in patients with chronic heart failure.
Watanabe E; Yasui K; Kamiya K; Yamaguchi T; Sakuma I; Honjo H; Ozaki Y; Morimoto S; Hishida H; Kodama I
Circ J; 2007 Apr; 71(4):471-8. PubMed ID: 17384445
[TBL] [Abstract][Full Text] [Related]
11. Expression and coassociation of ERG1, KCNQ1, and KCNE1 potassium channel proteins in horse heart.
Finley MR; Li Y; Hua F; Lillich J; Mitchell KE; Ganta S; Gilmour RF; Freeman LC
Am J Physiol Heart Circ Physiol; 2002 Jul; 283(1):H126-38. PubMed ID: 12063283
[TBL] [Abstract][Full Text] [Related]
12. A single amino acid difference between ether-a-go-go- related gene channel subtypes determines differential sensitivity to a small molecule activator.
Perry M; Sanguinetti MC
Mol Pharmacol; 2008 Apr; 73(4):1044-51. PubMed ID: 18162604
[TBL] [Abstract][Full Text] [Related]
13. Postmortem molecular analysis of KCNQ1, KCNH2, KCNE1 and KCNE2 genes in sudden unexplained nocturnal death syndrome in the Chinese Han population.
Liu C; Zhao Q; Su T; Tang S; Lv G; Liu H; Quan L; Cheng J
Forensic Sci Int; 2013 Sep; 231(1-3):82-7. PubMed ID: 23890619
[TBL] [Abstract][Full Text] [Related]
14. C-terminal β9-strand of the cyclic nucleotide-binding homology domain stabilizes activated states of Kv11.1 channels.
Ng CA; Ke Y; Perry MD; Tan PS; Hill AP; Vandenberg JI
PLoS One; 2013; 8(10):e77032. PubMed ID: 24204727
[TBL] [Abstract][Full Text] [Related]
15. Expression and functional characterization of the human ether-à-go-go-related gene (HERG) K+ channel cardiac splice variant in Xenopus laevis oocytes.
Aydar E; Palmer C
J Membr Biol; 2006; 211(2):115-26. PubMed ID: 17041783
[TBL] [Abstract][Full Text] [Related]
16. HERG mutation predicts short QT based on channel kinetics but causes long QT by heterotetrameric trafficking deficiency.
Paulussen AD; Raes A; Jongbloed RJ; Gilissen RA; Wilde AA; Snyders DJ; Smeets HJ; Aerssens J
Cardiovasc Res; 2005 Aug; 67(3):467-75. PubMed ID: 15958262
[TBL] [Abstract][Full Text] [Related]
17. [KCNQ1, KCNH2, KCNE1 and KCNE2 potassium channels gene variants in sudden manhood death syndrome].
Zhao QH; Liu C; Lu LW; Lü GL; Liu H; Tang SB; Quan L; Cheng JD
Fa Yi Xue Za Zhi; 2012 Oct; 28(5):337-41, 346. PubMed ID: 23213782
[TBL] [Abstract][Full Text] [Related]
18. Trafficking defect and proteasomal degradation contribute to the phenotype of a novel KCNH2 long QT syndrome mutation.
Mihic A; Chauhan VS; Gao X; Oudit GY; Tsushima RG
PLoS One; 2011 Mar; 6(3):e18273. PubMed ID: 21483829
[TBL] [Abstract][Full Text] [Related]
19. KCNE2 protein is expressed in ventricles of different species, and changes in its expression contribute to electrical remodeling in diseased hearts.
Jiang M; Zhang M; Tang DG; Clemo HF; Liu J; Holwitt D; Kasirajan V; Pond AL; Wettwer E; Tseng GN
Circulation; 2004 Apr; 109(14):1783-8. PubMed ID: 15066947
[TBL] [Abstract][Full Text] [Related]
20. Kv11.1 (ERG1) K+ channels localize in cholesterol and sphingolipid enriched membranes and are modulated by membrane cholesterol.
Balijepalli RC; Delisle BP; Balijepalli SY; Foell JD; Slind JK; Kamp TJ; January CT
Channels (Austin); 2007; 1(4):263-72. PubMed ID: 18708743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
